Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies

Rofecoxib (Vioxx© made by Merck Sharp & Dohme, the USA) is a non-steroidal anti-inflammatory drug which belongs to the group of selective inhibitors of cyclooxygenasis-2, i.e., coxibs. Rofecoxib was first registered in the USA, in May 1999. Since then the drug was received by millions of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Matysiak, Włodzimierz, Jodłowska-Jędrych, Barbara
Formato: Texto
Lenguaje:English
Publicado: Springer Vienna 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947012/
https://www.ncbi.nlm.nih.gov/pubmed/20721677
http://dx.doi.org/10.1007/s00709-010-0194-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947012/
https://www.ncbi.nlm.nih.gov/pubmed/20721677
http://dx.doi.org/10.1007/s00709-010-0194-9

Ejemplares similares